Metabolic reprogramming provides a novel approach to overcome resistance to BH3-mimetics in Malignant Pleural Mesothelioma
X.-M. Sun, G. J. Miles, A. Craxton, I. R. Powley, S. Galavotti, T. Chernova, A. Dawson, A. Nakas, A. E. Willis, K. Cain, M. MacFarlane
This study identifies metabolic reprogramming as a strategy to overcome resistance to BH3-mimetics in MPM by combining glycolytic inhibition with MCL-1 and BCL-2/BCL-XL targeting.
bioRxiv · Mar 31, 2023 · PreprintCell Biology